🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
122,22 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
148,73 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 1 día
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
28/11/1977 0,0113 USD
29/08/1977 0,0099 USD
31/05/1977 0,0099 USD
01/03/1977 0,0099 USD
30/11/1976 0,0099 USD
30/08/1976 0,0093 USD
01/06/1976 0,0093 USD
02/03/1976 0,0093 USD
01/12/1975 0,0093 USD
29/08/1975 0,0093 USD
02/06/1975 0,0093 USD
03/03/1975 0,0093 USD
30/08/1974 0,0093 USD
03/06/1974 0,0093 USD
04/03/1974 0,0093 USD
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
24/03/1971 1,33 1,33 1,31 1,32 -0,75% 1,50% 1.448.755
23/03/1971 1,33 1,33 1,32 1,33 -0,12% 1,00% 1.365.754
22/03/1971 1,32 1,33 1,32 1,33 +0,75% 0,75% 754.560
19/03/1971 1,32 1,32 1,31 1,32 -0,38% 0,88% 1.380.845
18/03/1971 1,32 1,32 1,31 1,32 +0,51% 1,01% 1.086.566
17/03/1971 1,31 1,32 1,31 1,32 +0,25% 1,01% 784.742
16/03/1971 1,30 1,32 1,30 1,31 +1,54% 1,65% 2.754.144
15/03/1971 1,27 1,29 1,27 1,29 +1,69% 1,69% 2.588.141
12/03/1971 1,26 1,27 1,26 1,27 +0,66% 0,52% 973.382
11/03/1971 1,26 1,27 1,25 1,26 +0,26% 1,45% 1.712.851
10/03/1971 1,26 1,27 1,26 1,26 +0,00% 0,79% 958.291
09/03/1971 1,26 1,27 1,26 1,26 -0,40% 0,52% 1.569.485
08/03/1971 1,27 1,28 1,26 1,26 -0,13% 1,70% 2.663.597
05/03/1971 1,27 1,28 1,27 1,27 -0,27% 0,79% 2.142.950
04/03/1971 1,26 1,27 1,26 1,27 +0,53% 0,40% 1.290.298
03/03/1971 1,27 1,27 1,26 1,26 -0,26% 1,05% 2.052.403
02/03/1971 1,28 1,28 1,26 1,27 -0,91% 1,17% 1.056.384
01/03/1971 1,28 1,28 1,27 1,28 +0,13% 0,90% 1.048.838
26/02/1971 1,28 1,28 1,27 1,28 +0,00% 0,78% 1.501.574
25/02/1971 1,26 1,28 1,26 1,28 +1,05% 1,32% 1.976.947
24/02/1971 1,28 1,28 1,25 1,26 -1,04% 1,94% 1.531.757
23/02/1971 1,26 1,28 1,26 1,28 +0,92% 1,57% 1.267.661
22/02/1971 1,29 1,29 1,26 1,26 -1,80% 1,80% 1.471.392
19/02/1971 1,30 1,30 1,29 1,29 -1,27% 1,40% 543.283
18/02/1971 1,30 1,31 1,30 1,30 +0,12% 0,89% 3.161.606
17/02/1971 1,30 1,31 1,30 1,30 +0,25% 0,89% 769.651
16/02/1971 1,31 1,32 1,29 1,30 -1,01% 2,28% 1.373.299
12/02/1971 1,33 1,33 1,31 1,31 -1,00% 1,50% 596.102
11/02/1971 1,33 1,33 1,32 1,33 -0,12% 1,13% 890.381
10/02/1971 1,30 1,33 1,30 1,33 +2,16% 1,90% 1.305.389